<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-vaccines-08-00197">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schmitz</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Beerli</surname>
    <given-names>R.R.</given-names>
   </name>
   <name>
    <surname>Bauer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Jegerlehner</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dietmeier</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Maudrich</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pumpens</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Saudan</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Bachmann</surname>
    <given-names>M.F.</given-names>
   </name>
  </person-group>
  <article-title>Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection</article-title>
  <source>Eur. J. Immunol.</source>
  <year>2012</year>
  <volume>42</volume>
  <fpage>863</fpage>
  <lpage>869</lpage>
  <pub-id pub-id-type="doi">10.1002/eji.201041225</pub-id>
  <?supplied-pmid 22531913?>
  <pub-id pub-id-type="pmid">22531913</pub-id>
 </element-citation>
</ref>
